Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€22.96

€22.96

0.440%
0.1
0.440%
-
 
15:47 / Tradegate WKN: 889384 / Symbol: MED / Name: Medifast / Stock / Food & Tobacco / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Medifast Inc. Stock

Medifast Inc. gained 0.440% compared to yesterday.

Pros and Cons of Medifast Inc. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medifast Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medifast Inc. 0.440% 1.736% -27.475% -70.137% -62.829% -91.626% -
Tootsie Roll Industries Inc. - 0.735% -1.439% -23.889% -6.803% 7.031% -18.174%
Central Gar.c.a NV - -2.186% 9.146% 13.291% -10.500% -13.942% 50.547%
Farmer Brothers Co. -1.470% 3.817% -6.849% 58.140% -4.895% -72.245% -83.819%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-25

General Impression of Medifast's Financials

Medifast (NYSE: MED) is a company in the Food & Tobacco industry with a solid financial performance over the last few years. The growth of total revenue, coupled with positive net income, is a good indicator of the company's growth prospects. Furthermore, the liquidity position, indicated by cash and total current assets, and the financial stability signaled by the increasing stockholder equity, has been improving over the past few years. However, a more in-depth analysis of the financial statements is necessary to better understand the company's overall financial health and potential risks.

Pros of Medifast's Financials

Comments

Medifast, Inc. (NYSE: MED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for MED provided by MarketBeat
Show more

News

LifeMD Can Surge on Its GLP-1 Offerings: https://www.marketbeat.com/logos/articles/med_20240525153019_chartsz-lfmd.jpg
LifeMD Can Surge on Its GLP-1 Offerings

LifeMD Inc. (NASDAQ: LFMD) is a leading telehealth provider operating an end-to-end virtual healthcare platform. LifeMD operates a direct-to-consumer (DTC) model focused on offering on-demand

LifeMD expands telehealth GLP-1weight-loss service with Medifast: https://www.marketbeat.com/logos/articles/med_20231217154404_chart-lfmd.jpg
LifeMD expands telehealth GLP-1weight-loss service with Medifast

LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing with no health insurance required. It